| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
20,743 |
12,539 |
$463K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
6,431 |
3,450 |
$161K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,861 |
715 |
$38K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,072 |
762 |
$34K |
| 87428 |
|
1,489 |
834 |
$32K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
762 |
487 |
$24K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,790 |
1,916 |
$21K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
553 |
264 |
$14K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
530 |
320 |
$12K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
878 |
598 |
$6K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
410 |
235 |
$6K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
153 |
112 |
$5K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,181 |
416 |
$4K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
157 |
104 |
$3K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
303 |
133 |
$3K |
| 99460 |
|
75 |
40 |
$2K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
66 |
47 |
$2K |
| 99215 |
Prolong outpt/office vis |
92 |
73 |
$2K |
| 87634 |
|
82 |
37 |
$2K |
| 87807 |
|
282 |
152 |
$1K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
50 |
41 |
$1K |
| 99462 |
|
75 |
26 |
$1K |
| 90670 |
|
887 |
251 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
591 |
375 |
$1K |
| 99173 |
|
930 |
473 |
$1K |
| 81002 |
|
1,131 |
675 |
$853.37 |
| 90648 |
|
426 |
138 |
$744.00 |
| 90686 |
|
178 |
81 |
$611.03 |
| 90680 |
|
635 |
160 |
$576.00 |
| 92551 |
|
388 |
147 |
$567.90 |
| 90633 |
|
61 |
25 |
$192.00 |
| 36415 |
Collection of venous blood by venipuncture |
532 |
355 |
$179.20 |
| 90677 |
|
68 |
52 |
$176.00 |
| 96161 |
|
430 |
106 |
$129.36 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
192 |
133 |
$105.50 |
| 20610 |
|
21 |
14 |
$97.66 |
| 90723 |
|
34 |
14 |
$88.00 |
| 73110 |
|
29 |
13 |
$68.28 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
355 |
254 |
$64.54 |
| 81003 |
|
128 |
26 |
$57.00 |
| 36416 |
|
58 |
27 |
$30.00 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
21 |
14 |
$24.17 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
22 |
12 |
$15.00 |
| 3008F |
|
1,461 |
804 |
$0.00 |
| 1036F |
|
410 |
155 |
$0.00 |
| 99000 |
|
178 |
142 |
$0.00 |
| 3074F |
|
364 |
143 |
$0.00 |
| 81000 |
|
175 |
91 |
$0.00 |
| 1125F |
|
17 |
14 |
$0.00 |
| 3079F |
|
27 |
12 |
$0.00 |
| 1126F |
|
14 |
12 |
$0.00 |
| 1159F |
|
1,651 |
566 |
$0.00 |
| 3078F |
|
475 |
190 |
$0.00 |
| 1160F |
|
1,054 |
438 |
$0.00 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
27 |
18 |
$0.00 |
| 90461 |
|
850 |
222 |
$0.00 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
1,098 |
320 |
$0.00 |